Please use this identifier to cite or link to this item:
|Title:||Comparison between fixed-dose, intracoronary bolus-only versus standard weight-adjusted dose, intravenous bolus and infusion administration of abciximab in patients undergoing primary percutaneous coronary intervention|
|Authors:||Lee, C.-H. |
ST-segment elevation myocardial infarction
|Source:||Lee, C.-H., Ngo, H.M., Sewianto, A., Nguyen, T.H., Lee, J., Teo, S.-G., Low, A.F., Tan, H.-C. (2010). Comparison between fixed-dose, intracoronary bolus-only versus standard weight-adjusted dose, intravenous bolus and infusion administration of abciximab in patients undergoing primary percutaneous coronary intervention. International Journal of Cardiology 145 (2) : 355-357. ScholarBank@NUS Repository. https://doi.org/10.1016/j.ijcard.2010.02.017|
|Abstract:||We studied the safety and effectiveness of fixed-dose, intracoronary bolus-only abciximab in 195 patients who underwent primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. The patients were divided into 2 groups: Group A (n = 120, 61.5%) received fixed-dose, intracoronary bolus-only, abciximab 10 mg; and Group B (n = 75, 38.5%) received standard intravenous bolus (0.25 mg/kg) and maintenance abciximab infusion of 0.125 μg/kg/min for 12 h. There was no statistically significant difference in the baseline and post-procedure TIMI flow between Groups A and B. Final TIMI 3 flow was achieved in 90.0% and 89.3% of the patients in Groups A and B, respectively (p = 0.14). Final TIMI myocardial perfusion grade 2/3 was achieved in 92.5% and 96.0% of the patients in Groups A and B, respectively (p = 0.45). The six-month clinical outcomes were similar between Groups A and B (8.3% versus 5.3%, p = 0.62). © 2010 Elsevier Ireland Ltd. All rights reserved.|
|Source Title:||International Journal of Cardiology|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Mar 7, 2018
WEB OF SCIENCETM
checked on Feb 5, 2018
checked on Mar 11, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.